Undervalued Biotech's

Description:

With the merger between Pfizer (PFE) and Wyeth (WYE), the attempted takeover of Genentech (DNA) by Roche, and the overall positive action in Amgen (AMGN), Celgene Corp (CELG), Genzyme (GENZ), and Geilead (GILD) recently, many analysts and investors believe that 2009 will be a positive year for the biotech industry as a whole.
Important events in the biotech space include Dendreon’s (DNDN) binary data announcement on its key drug Provenge in early April and Genentech’s (DNA) update on various uses for Avastin late April.

Most Viewed Portfolios

View All

Articles

4 Huge Stocks to Trade (or Not)

08.18.14 | 12:00 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

5 Rocket Stocks to Buy for Gains This Week

08.18.14 | 11:45 AM

BALTIMORE (Stockpickr) -- The big bounce in the S&P 500 followed through last week, ending the big index 1.2% higher on Friday than it started Mond...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter